+154,200.8%
NVDA vs CME
+8,429.7%
+145,771.0%
-85.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | -0.1% | -4.2% | -4.3% |
| 7D | -8.5% | +2.7% | -11.2% | -9.5% |
| 30D | -27.3% | +13.5% | -40.8% | -31.2% |
| 3M | -25.8% | +20.9% | -46.7% | -31.9% |
| 6M | -24.6% | +11.5% | -36.1% | -29.1% |
| YTD | -10.7% | +19.5% | -30.1% | -19.0% |
| 1Y | -14.0% | +17.2% | -31.3% | -21.6% |
| 3Y | +244.9% | +65.1% | +179.7% | +162.8% |
| 5Y | +449.3% | +73.1% | +376.2% | +309.8% |
| 10Y | +7,600.6% | +305.3% | +7,295.3% | +3,708.2% |
| All | +154,200.8% | +8,429.7% | +145,771.0% | +21,564.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling